How do the requirements for sequence listings differ between WIPO ST.25 and WIPO ST.26?
The requirements for sequence listings differ significantly between WIPO ST.25 and WIPO ST.26. WIPO ST.25 was the standard used for applications filed before July 1, 2022, while WIPO ST.26 applies to applications filed on or after that date. The MPEP notes: “See MPEP §§ 2412 – 2419 for guidance on WIPO ST.26 requirements for applications…
Read MoreWhat are the standard single-letter codes for modified and unusual nucleotides in WIPO ST.25?
What are the standard single-letter codes for modified and unusual nucleotides in WIPO ST.25? WIPO ST.25 provides standard single-letter codes for modified and unusual nucleotides in sequence listings. According to MPEP 2423: “The nucleotides listed in Appendix 2, Table 2, are the only permitted nucleotides. Where a sequence includes “other” nucleotides, they must be represented…
Read MoreWhen did the requirements for nucleotide and amino acid sequence data change?
The requirements for nucleotide and amino acid sequence data changed on July 1, 2022. The MPEP section notes: “[Editor Note: This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). See MPEP §§ 2412 – 2419 for…
Read MoreWhat are the symbols and format requirements for nucleotide and amino acid sequence data in patent applications?
The symbols and format requirements for nucleotide and amino acid sequence data in patent applications are outlined in 37 CFR 1.822. This regulation specifies the standards for presenting sequence data in patent applications. It’s important to note that “Appendices A through F referenced in 37 CFR 1.822 are reproduced in MPEP § 2422(I).” These appendices…
Read MoreWhat are the rules for representing modified amino acids in WIPO ST.25 sequence listings?
What are the rules for representing modified amino acids in WIPO ST.25 sequence listings? The representation of modified amino acids in WIPO ST.25 sequence listings follows specific rules as outlined in MPEP 2423: “Modified amino acids must be represented as the corresponding unmodified amino acids in the sequence itself if possible. Any modified amino acids…
Read MoreHow should gaps in nucleotide sequences be represented in WIPO ST.25 format?
How should gaps in nucleotide sequences be represented in WIPO ST.25 format? According to MPEP 2423, gaps in nucleotide sequences should be represented using a specific symbol in WIPO ST.25 format: “Gaps of indeterminate length in the sequence must be represented by a series of the lower case letter “n”, the number of “n” residues…
Read MoreHow should branched sequences be represented in WIPO ST.25 format?
How should branched sequences be represented in WIPO ST.25 format? Branched sequences require special handling in WIPO ST.25 format. According to MPEP 2423: “A sequence that contains regions of specifically defined residues separated by one or more regions of consecutively branched residues comprising any one or more of the following: ‘J’, ‘O’, or ‘Z’, must…
Read More